Anna Krupa has a diverse work experience in the pharmaceutical industry. Anna started their career as a Pharmacy Intern at Fairmount Behavioral Health System in 2012 and continued in that role until 2017. In 2016, they had a short externship at Pfizer in the PSSR department. From 2017 to 2019, Anna worked at Luitpold Pharmaceuticals, Inc. as a Clinical R&D/Clinical Ops/PV, where they were responsible for various tasks related to study management and medical monitoring. Anna also achieved a co-authorship in a hematology/oncology randomized clinical trial during their time at Luitpold Pharmaceuticals. Following this, Anna worked as an Adjunct Professor of Pharmacy at St. John's University from 2017 to 2019. In 2019, they joined CSL Behring as a Senior Clinical Scientist and held that position until 2023. Currently, Anna is working as a Clinical Scientist (AD) at MorphoSys.
Anna Krupa completed their education in a chronological order as follows:
From 2016 to 2018, Anna attended Temple University and obtained a Master's Degree in Global Clinical and Pharmacovigilance Regulations.
Between 2013 and 2017, Anna pursued their Doctor of Pharmacy (Pharm.D.) at Temple University School of Pharmacy.
From 2004 to 2007, Anna studied Applied Linguistics at the National Aerospace University -'Kharkiv Aviation Institute'. The degree obtained during this period is not specified.
Additionally, Anna has obtained various certifications throughout their education and career:
In April 2021, Anna acquired a Basic Life Support Certification (CPR & AED) from APhA Foundation.
In October 2018, Anna obtained a Research Ethics Certification from FHI 360.
In September 2018, Anna obtained a Pennsylvania State Board of Pharmacy Licensure from the National Association of Boards of Pharmacy.
In June 2018, Anna obtained a Teaching Certification from St. John's University.
In March 2017, Anna acquired the Pharmacy-Based Immunization Delivery certification. The institution granting this certification is not specified.
In May 2015, Anna obtained a Clinical Research Track Certification from Temple University.
January, 2023 - present